We have found 12 results when searching "Liraglutide"
East Region Formulary Prepared by S McNeill Sept 2025/ Checked by C Satti Sept 2025 Summary of updates to East Region Formulary (ERF) website. The purpose of this summary is to detail the main cha...
The NHS Lothian Policy and Procedures for the Shared Care of Medicines is available from the NHS Lothian Medicines Governance Policies page. Template documents relating to local shared care arrangemen...
East Region Formulary ERFC Minutes 28 September 2022 Page 1 of 17 East Region Formulary Committee Minutes Date: 28 September 2022 Time: 2pm – 4pm Location: MS Teams Present: Alison Casey Sen...
East Region Formulary ERFC Minutes 7 June 2023 Page 1 of 17 East Region Formulary Committee Minutes Date: 7 June 2023 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning (Acting) Assoc...
East Region Formulary ERFC Minutes 28 May 2025 Page 1 of 15 East Region Formulary Committee Minutes Date: 28 May 2025 Time: 2.00pm – 4:15pm Location: MS Teams Present: Carla Capaldi Senior Pra...
East Region Formulary ERFC Minutes 25 May 2022 Page 1 of 14 East Region Formulary Committee Minutes Date: 25th May 2022 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning Lead Pharmac...
East Region Formulary ERFC Minutes 24 November 2021 Page 1 of 24 East Region Formulary Committee Minutes Date: 24 November 2021 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning Lead P...
585/09 : Type 2 Diabetes. SMC Restriction: Liraglutide is restricted to use as a third-line antidiabetic agent.
1044/15 : For the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with basal insulin when this, together with diet and exercise, does not provide adequate...
1088/15 : Treatment of adults with type 2 diabetes mellitus to improve glycaemic control in combination with oral glucose-lowering medicinal products when these alone or combined with a GLP-1 receptor...
